Cabio Biotech (Wuhan) Co (SHSE:688089) FCF Margin % : -7.05% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cabio Biotech (Wuhan) Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-8.3 Mil. Cabio Biotech (Wuhan) Co's Revenue for the three months ended in Mar. 2024 was ¥117.0 Mil. Therefore, Cabio Biotech (Wuhan) Co's FCF Margin % for the quarter that ended in Mar. 2024 was -7.05%.

As of today, Cabio Biotech (Wuhan) Co's current FCF Yield % is -7.56%.

The historical rank and industry rank for Cabio Biotech (Wuhan) Co's FCF Margin % or its related term are showing as below:

SHSE:688089' s FCF Margin % Range Over the Past 10 Years
Min: -51.55 Med: 19.03 Max: 34.88
Current: -35.64

During the past 11 years, the highest FCF Margin % of Cabio Biotech (Wuhan) Co was 34.88%. The lowest was -51.55%. And the median was 19.03%.

SHSE:688089's FCF Margin % is ranked better than
63.58% of 1038 companies
in the Biotechnology industry
Industry Median: -136.31 vs SHSE:688089: -35.64

Cabio Biotech (Wuhan) Co FCF Margin % Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co FCF Margin % Chart

Cabio Biotech (Wuhan) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

34.88

34.87

-19.98

-16.86

-51.55

Cabio Biotech (Wuhan) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-77.99	-34.39	-63.40	-35.50	-7.05

Competitive Comparison of Cabio Biotech (Wuhan) Co's FCF Margin %

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cabio Biotech (Wuhan) Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's FCF Margin % falls into.

Cabio Biotech (Wuhan) Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cabio Biotech (Wuhan) Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-228.79	/	443.803
	=	-51.55 %

Cabio Biotech (Wuhan) Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-8.255	/	117.02
	=	-7.05 %

Cabio Biotech (Wuhan) Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cabio Biotech (Wuhan) Co (SHSE:688089) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 999, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, CHN, 430073

Website

http://www.cabio.cn

Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.

Executives

Shang Yun	Core technical personnel
Wang Hua Biao	Directors, senior managers
Geng An Feng	senior management
Du Bin	Director
Yi Hua Rong	senior management
Ma Tao	senior management
Li Xiang Yu	senior management
Wu Yu Jun	Supervisors
Xiao Min	senior management
Wang Zhi Ming	senior management
Lu Shu Huan	Core technical personnel
Yi De Wei	Director

Cabio Biotech (Wuhan) Co (SHSE:688089) Headlines

No Headlines